ArticleScientific reports2025
A new flexible odd type-G family of distributions with properties and applications in the biomedical sector.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Complementary Asymmetric-Odds Weibull Distribution: A Flexible Lifetime Model with Applications to Hazard Rate Modeling and Change-Point Analysis.Entropy (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, we propose a new family of probability distributions called the new flexible odd type-G family of distributions. We have used the Weibull distribution as the base reference to introduce a new heavy-tailed distribution, which we have fittingly named the new flexible odd-type Weibull distribution. The hazard function of the newly proposed distribution exhibits various shapes, such as increasing, decreasing, unimodal, S-shaped, J-shaped, reverse J-shaped, and bathtub shapes. For the proposed distribution, we have derived various distributional properties, including moments, moment generating function, characteristic function, mean deviation from median, and order statistics. Furthermore, actuarial measures, such as Value at Risk and Tail Value at Risk, are calculated, and it is empirically demonstrated that the proposed distribution exhibits heavy-tailed behavior. To estimate the model parameter, we applied the maximum likelihood estimation method and conducted a simulation study to assess its performance for the proposed distribution. From the simulation results, it is confirmed that as the sample size increases, the mean square error and biases decrease and approach zero. Finally, we evaluated three real data sets from the biomedical field to demonstrate the flexibility and superiority of the proposed distribution in comparison to the other nine probability distributions. The analyzed results (numerically as well as graphically) show that the newly proposed model provides a superior fit compared to the competing distributions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.